CD4 and colon adenocarcinoma: Last, efficient CD4+ T-cell priming was observed with B3 and F6 pro-B cell leukemia cells but not with B16 melanoma or MCA-38 colon adenocarcinoma cells, although all these tumor cell lines can cross-dress DCs.54